We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
-10.74%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$523M
AUM Growth
-$538M
(-51%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
16.14%
Holding
381
New
50
Increased
12
Reduced
195
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$4.39M |
| 2 |
EGLT
Egalet Corporation
EGLT
|
+$4.21M |
| 3 |
Teladoc Health
TDOC
|
+$3.72M |
| 4 |
FRSH
Papa Murphy's Holdings, Inc
FRSH
|
+$3.37M |
| 5 |
CORI
Corium International, Inc.
CORI
|
+$3.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADPT
Adeptus Health Inc
ADPT
|
+$26.9M |
| 2 |
Repligen
RGEN
|
+$15.8M |
| 3 |
AAC
AAC Holdings
AAC
|
+$15.3M |
| 4 |
TWOU
2U Inc
TWOU
|
+$9.16M |
| 5 |
CALD
Callidus Software, Inc.
CALD
|
+$8.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.22% |
| 2 | Technology | 24.65% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 10.1% |
| 5 | Communication Services | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
76
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.21M | 0.42% |
42,600
-5,500
| -11% | -$361K |
|
|
PTX
77
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.2M | 0.42% |
69,630
-51,910
| -43% | -$2.48M |
|
|
CIO
78
DELISTED
City Office REIT
CIO
| $2.16M | 0.41% |
190,400
-200,700
| -51% | -$2.34M |
|
79
Bio-Techne
TECH
$11.3B
| $2.15M | 0.41% |
92,964
-24,704
| -21% | -$619K |
|
|
NVDQ
80
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.11M | 0.4% |
202,507
| – | – |
|
81
Orion Group Holdings
ORN
$418M
| $2.11M | 0.4% |
352,300
-347,400
| -50% | -$2.43M |
|
82
Chefs' Warehouse
CHEF
$4.5B
| $2.05M | 0.39% |
144,518
-104,700
| -42% | -$1.78M |
|
|
OIG
83
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $2.01M | 0.39% |
9,733
-10,008
| -51% | -$2.08M |
|
|
BELFB
84
Bel Fuse Inc Class B
BELFB
$4.21B
| $2.01M | 0.38% |
103,509
-322
| -0.3% | -$6.45K |
|
|
BREW
85
DELISTED
Craft Brew Alliance, Inc.
BREW
| $2M | 0.38% |
250,387
-78,613
| -24% | -$709K |
|
86
Malibu Boats
MBUU
$567M
| $1.96M | 0.37% |
140,100
-234,932
| -63% | -$4.23M |
|
|
CLVS
87
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.94M | 0.37% |
21,129
-6,614
| -24% | -$572K |
|
88
Natera
NTRA
$46.4B
| $1.85M | 0.35% |
+170,600
| New | +$2.89M |
|
89
Varonis Systems
VRNS
$5B
| $1.81M | 0.35% |
348,600
-316,500
| -48% | -$2.2M |
|
90
PennyMac Financial
PFSI
$4.02B
| $1.8M | 0.34% |
112,310
-92,700
| -45% | -$1.61M |
|
91
Radiant Logistics
RLGT
$395M
| $1.78M | 0.34% |
+398,800
| New | +$2.45M |
|
92
Dare Bioscience
DARE
$21M
| $1.74M | 0.33% |
3,958
| – | – |
|
93
uniQure
QURE
$3.22B
| $1.73M | 0.33% |
84,600
+29,600
| +54% | +$780K |
|
|
ACGN
94
DELISTED
Aceragen Inc
ACGN
| $1.68M | 0.32% |
3,680
| – | – |
|
|
AMBR
95
DELISTED
Amber Road Inc
AMBR
| $1.66M | 0.32% |
393,555
-464,538
| -54% | -$2.49M |
|
96
Onto Innovation
ONTO
$15.3B
| $1.63M | 0.31% |
134,308
-162,992
| -55% | -$2.31M |
|
|
MTLS
97
Materialise
MTLS
$396M
| $1.61M | 0.31% |
210,000
-161,600
| -43% | -$1.38M |
|
98
Ooma
OOMA
$604M
| $1.61M | 0.31% |
+232,306
| New | +$2.17M |
|
99
Ollie's Bargain Outlet
OLLI
$4.94B
| $1.61M | 0.31% |
+99,731
| New | +$1.85M |
|
100
vTv Therapeutics
VTVT
$139M
| $1.59M | 0.3% |
+6,100
| New | +$2.13M |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Wall Street Associates held 381 positions worth $523M, down 51% from $1.06B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wall Street Associates withdrew a net $439M in Q3 2015, closing 68 positions and reducing 195 holdings. Its most notable exit was AAC Holdings, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in Neos Therapeutics, Inc worth $4.19M.
- Wall Street Associates's largest Q3 2015 buy was Neos Therapeutics, Inc: 199,343 shares worth $4.19M.
- Wall Street Associates added most to uniQure in Q3 2015, an estimated $780K increase.
- Wall Street Associates's biggest Q3 2015 reduction was Adeptus Health Inc, cutting an estimated $26.9M.
- Wall Street Associates fully exited AAC Holdings in Q3 2015, selling an estimated $15.3M.
- Wall Street Associates's ten largest holdings make up 16% of its $523M portfolio in Q3 2015.
- Wall Street Associates opened 50 new positions and closed 68 in Q3 2015.
- Wall Street Associates's portfolio value fell 51% quarter-over-quarter to $523M.
Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.